Global Thoracic Stent Graft Market Size By Type (Hemodialysis Access Graft, Endovascular Stent Graft), By Application (Cardiovascular Diseases, Cardiac Aneurysm), By Region, And Segment Forecasts, 202...

The Global Thoracic Stent Graft Market was valued at USD 2.3 billion in 2023 and is projected to reach USD 4.5 billion by 2031, growing at a CAGR of 8.7% during the forecast period from 2023 to 2031. The market is driven by the increasing prevalence of thoracic aortic aneurysms, rising geriatric population, and advancements in minimally invasive endovascular repair techniques. Thoracic stent grafts are widely adopted due to their reduced recovery time and lower post-operative complications compared to traditional surgical methods. Growing awareness among patients and physicians about endovascular treatment options further contributes to market expansion.

Drivers

1. Rising Incidence of Thoracic Aortic Aneurysms (TAA):

The global incidence of TAA has been increasing, particularly among aging populations, fueling the demand for effective and less invasive treatment solutions such as thoracic stent grafts.

2. Advancements in Endovascular Technologies:

Continuous improvements in stent graft designs, such as low-profile systems and better conformability to complex anatomies, have increased the success rates of thoracic endovascular aortic repair (TEVAR), driving wider adoption.

3. Growth in Geriatric Population:

The elderly are more prone to cardiovascular conditions, including aneurysms. The minimally invasive nature of stent grafts makes them especially suitable for this demographic, contributing to increased procedure volumes.

Restraints

1. High Procedure and Device Costs:

Thoracic stent grafts and the associated TEVAR procedures are cost-intensive, which can hinder market penetration in cost-sensitive and low-income regions.

2. Risk of Post-Operative Complications:

Despite being less invasive, TEVAR carries risks such as endoleaks, device migration, and spinal cord ischemia, which can impact long-term outcomes and limit market growth.

Opportunity

1. Emerging Markets and Health Infrastructure Improvements:

The expansion of healthcare infrastructure in emerging markets, coupled with increased healthcare spending, opens new avenues for the adoption of advanced vascular repair technologies.

2. Integration of Imaging and AI for Personalized Stent Design:

Developments in imaging and artificial intelligence enable better preoperative planning and customized stent grafts, potentially improving outcomes and expanding usage scenarios.

Market by System Type Insights

Based on system type, Self-expanding stent grafts held the largest market share in 2023. Their flexibility and adaptability to varied aortic anatomies have made them a preferred choice among interventional cardiologists and vascular surgeons. Balloon-expandable stent grafts, though used less frequently, are gaining traction due to their high radial strength and precision placement, especially in anatomically challenging cases.

Market by End-use Insights

In 2023, Hospitals and Surgical Centers emerged as the dominant end-use segment, accounting for more than 60% of the total market share. These facilities typically house advanced imaging technologies and specialized vascular teams, which are critical for performing TEVAR procedures. Ambulatory Surgical Centers (ASCs) are expected to grow at the fastest pace, driven by the trend toward outpatient procedures and shorter hospital stays.

Market by Regional Insights

North America led the global thoracic stent graft market in 2023 due to high healthcare expenditure, early adoption of innovative technologies, and the presence of major market players. Asia-Pacific is poised to register the highest growth rate during the forecast period, fueled by increasing awareness, healthcare infrastructure development, and a growing patient pool suffering from vascular disorders in countries like China and India.

Competitive Scenario

Key players in the Global Thoracic Stent Graft Market include Medtronic plc, Cook Medical, Terumo Corporation, Gore Medical, and Cardinal Health. These companies are focusing on geographic expansion, product innovation, and clinical trials to gain competitive advantage. Recent developments include:

In 2023, Medtronic launched the latest generation of low-profile thoracic stent graft systems for improved anatomical fit.

In 2024, Cook Medical announced successful clinical trial outcomes for its new branch stent graft technology, aimed at complex thoracoabdominal aneurysms.

In 2025, Gore Medical expanded its production capabilities to meet growing demand in Asia-Pacific.

Scope of Work – Global Thoracic Stent Graft Market

Report Metric Details

Market Size (2023) USD 2.3 Billion

Projected Market Size (2031) USD 4.5 Billion

CAGR (2023–2031) 8.7%

Market Segments By System Type (Self-expanding, Balloon-expandable), By End-use (Hospitals & Surgical Centers, ASCs), By Region

Growth Drivers Aging population, Increasing cases of TAA, Advancements in endovascular repair

Opportunities Growth in emerging markets, AI-driven customized graft design

Key Market Developments

2023: Medtronic introduced a next-gen self-expanding stent graft with enhanced flexibility and lower profile.

2024: Terumo partnered with leading cardiovascular institutes in Europe for R&D on branch endografts.

2025: Gore Medical established a dedicated TEVAR innovation center in Singapore.

FAQs

1) What is the current market size of the Global Thoracic Stent Graft Market?

The market was valued at USD 2.3 billion in 2023.

2) What is the major growth driver of the Global Thoracic Stent Graft Market?

The increasing incidence of thoracic aortic aneurysms and the rise in the geriatric population are major growth drivers.

3) Which is the largest region during the forecast period in the Global Thoracic Stent Graft Market?

North America is expected to remain the largest region.

4) Which segment accounted for the largest market share in the Global Thoracic Stent Graft Market?

The self-expanding stent graft segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Thoracic Stent Graft Market?

Key players include Medtronic plc, Cook Medical, Gore Medical, Terumo Corporation, and Cardinal Health.